Status:
COMPLETED
Esophagectomy in Patients With Liver Cirrhosis
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Esophageal Cancer
Liver Cirrhosis
Eligibility:
All Genders
18-100 years
Brief Summary
Retrospective and confounder adjusted comparison of perioperative and longterm outcomes of patients requiring an esophagectomy for esophageal cancer with and without concomitant liver cirrhosis.
Eligibility Criteria
Inclusion
- age ≥ 18 years
- primary esophageal cancer with indication for curative treatment
- follow up period ≥ 5 years
- LC cohort: pre- or intraoperative histological proof of liver cirrhosis
Exclusion
- recurrent esophageal cancer
- missing indication for curative treatment of esophageal cancer
- esophagectomy for benign esophageal lesions
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 10 2021
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT04809870
Start Date
October 1 2020
End Date
April 10 2021
Last Update
May 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Hamburg Medical Institutions
Hamburg, Germany